Inova Translational Medicine Institute, Personalis Partner for Diagnostic Genome Interpretation | GenomeWeb

This article has been updated to reflect the increased size of a study by Inova.

NEW YORK (GenomeWeb News) − The Inova Translational Medicine Institute has teamed up with Personalis for the analysis and clinical interpretation of whole-genome sequencing data from patients with undiagnosed syndromes, the partners said today.

Under the collaboration, ITMI, a non-profit research institute that is part of the Inova Health System, will perform whole-genome sequencing on patients with suspected genetic disease who have not been able to obtain a molecular diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.